Comparison of American and European Guidelines for the Management of Patients With Valvular Heart Disease.

Autor: Inanc IH; Kırıkkale Yuksek Ihtisas Hospital, Department of Cardiology, Kırıkkale, Turkey. Electronic address: ihinanc@yahoo.com., Cilingiroglu M; University of Texas in Houston, MD Anderson Cancer Center, Houston, TX, United States of America., Iliescu C; University of Texas in Houston, MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: ciliescu@mdanderson.org., NInios V; Department of Cardiology, Interbalkan European Medical Center, Thessaloniki, Greece., Matar F; Department of Cardiology, University of South Florida, Tampa, FL, United States of America. Electronic address: fmatar@health.usf.edu., Ates I; Department of Cardiology, Sisli Kolan International Hospital, Istanbul, Turkey., Toutouzas K; Hippocrateion Athens General Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: ktoutouz@otenet.gr., Hermiller J; Department of Cardiology, St Vincent Heart Center, Indianapolis, IN, United States of America., Marmagkiolis K; University of Texas in Houston, MD Anderson Cancer Center, Houston, TX, United States of America; Department of Cardiology, University of South Florida, Tampa, FL, United States of America.
Jazyk: angličtina
Zdroj: Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2023 Feb; Vol. 47, pp. 76-85. Date of Electronic Publication: 2022 Oct 17.
DOI: 10.1016/j.carrev.2022.10.005
Abstrakt: This review compares the recommendations of the recent 2020 American College of Cardiology (ACC)/American Heart Association (AHA) and 2021 European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS) guidelines on the management of patients with valvular heart disease (VHD). ACC/AHA and ESC/EACTS guidelines are both the updated versions of previous 2017 documents. Both guidelines fundamentally agree on the extended indications of percutaneous valve interventions, the optimal use of imaging modalities other than 2D echocardiography, the importance of a multidisciplinary Heart Team as well as active patient participation in clinical decision making, more widespread use of NOACs and earlier intervention with lower left ventricular dilatation thresholds to decrease long-term mortality. The differences between the guidelines are mainly related to the classification of the severity of valve pathologies and frequency of follow-up, level of recommendations of valve intervention indications in special patient groups such as frail patients and the left ventricular diameter and ejection fraction thresholds for intervention.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2022 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: